Skip to main content
Log in

Synthesis and pharmacological properties of 3-(2-methyl-furan-3-yl)-4-substituted-Δ2-1,2,4-triazoline-5-thiones

  • Research Article
  • Published:
Central European Journal of Chemistry

Abstract

By the reaction of 2-methyl-furan-3-carboxylic acid hydrazide with isothiocyanates, 1-[(2-methyl-furan-3-yl)carbonyl]-4-substituted thiosemicarbazides 1 were obtained. Further cyclization with 2% NaOH led to the formation of 3-(2-methyl-furan-3-yl)-4-substituted-Δ2-1,2,4-triazoline-5-thiones 2. The pharmacological effects of 2 on the central nervous system in mice were investigated. Strong antinociceptive properties of the investigated derivatives were observed in a wide range of doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. B. Modzelewska-Banachiewicz, J. Banachiewicz, A. Chodkowska, E. Jagiełłlo-Wójtowicz, L. Mazur, Eur. J. Med. Chem. 39, 873 (2004)

    Article  CAS  Google Scholar 

  2. X-Y. Sun et al., Arch. Pharm. Res. 29, 1080 (2006)

    Article  CAS  Google Scholar 

  3. U. Misra, A. Hitkari, A.K. Saxena, S. Gurtu, K. Shanker, Eur. J. Med. Chem. 31, 629 (1996)

    Article  CAS  Google Scholar 

  4. S.H.L. Chiu, S.E.W Huskey, Drug Metabol. Dispos. 26, 838 (1998)

    CAS  Google Scholar 

  5. B. Tozkoparan et al., Arzneimittelforschung 55, 533 (2005)

    CAS  Google Scholar 

  6. O.A. Al-Deeb et al., Arzneimittelforschung 56, 40 (2006)

    CAS  Google Scholar 

  7. B.S. Holla et al., Farmaco 56, 565 (2001)

    Article  CAS  Google Scholar 

  8. H. Shivarama Holla, B. Sooryanarayana Rao, B.K. Sarojini, P.M. Akberali, N. Suchetha Kumari, Eur. J. Med. Chem. 41, 657 (2006)

    Article  CAS  Google Scholar 

  9. G. Turan-Zitouni, Z.A. Kaplancikli, K. Erol, F.S. Kiliç, Il Farmaco 54, 218 (1999)

    Article  CAS  Google Scholar 

  10. M. De La Rosa et al., Bioorg. Med. Chem. Lett. 16, 4444 (2006)

    Article  CAS  Google Scholar 

  11. A.A. Ikizler, C.B. Johansson, O. Bekircan, C. Çelik, Acta Polon. Pharm.-Drug Research 56, 283 (1999)

    CAS  Google Scholar 

  12. S. Demirayak, K. Benkli, K. Güven, Eur. J. Med. Chem., 35, 1037 (2000)

    Article  CAS  Google Scholar 

  13. X-P. Hui, L-M. Zhang, Z-Y. Zhang, Q. Wang, F. Wang, J. Chin. Chem. Soc., 47, 535 (2000)

    CAS  Google Scholar 

  14. Ch-H. Chu, X-P. Hui, Y. Zhang, Z-Y. Zhang, Z.-Ch.. Li, R.-A. Liao, J. Chin. Chem. Soc. 48, 121 (2001)

    CAS  Google Scholar 

  15. M. Wujec, M. Pitucha, M. Dobosz, U. Kosikowska, A. Malm, Acta Pharm. 54, 251 (2004)

    CAS  Google Scholar 

  16. E.B. Åkerblom, D.E.S. Campbell, Eur. J. Med. Chem. 16, 312 (1973)

    Google Scholar 

  17. F.C. Meotti et al., Environ. Toxicol. Pharmacol. 37, 37 (2003)

    Article  CAS  Google Scholar 

  18. J. Malmström et al., J. Am. Chem. Soc. 123, 3434 (2001)

    Article  CAS  Google Scholar 

  19. J.R. Boissier, J. Tardy, J.C. Diverres, Med. Exp. 3, 81 (1960)

    CAS  Google Scholar 

  20. C. Aron, P. Simon, C. Larousse, J.R. Boissier, Neuropharmacology 10, 459 (1971)

    Article  CAS  Google Scholar 

  21. R.D. Porsolt, A. Bertin, M. Deniel, M. Jalfre, Arch. Int. Pharmacodyn. Thér. 229, 327 (1977)

    CAS  Google Scholar 

  22. L.B. Witkin, C.F. Heubner, E. O’Keete, P. Spitatalitta, A.J. Plummer, J. Pharmacol. Exp. Ther. 133, 400 (1961)

    CAS  Google Scholar 

  23. S.J. Corne, R.W. Pickering, B.T. Warner, Br. J. Pharmacol. 20, 106 (1963)

    CAS  Google Scholar 

  24. A.D. Becke, Phys. Rev. A 38, 3098 (1988)

    Article  CAS  Google Scholar 

  25. A.D. Becke, J. Chem. Phys. 98, 5648 (1993)

    Article  CAS  Google Scholar 

  26. J.P. Perdew et al., Phys. Rev. B 46, 13584 (1992)

    Article  Google Scholar 

  27. P.C. Hariharan, J.A. Pople, Theor. Chim. Acta 28, 213 (1973)

    Article  CAS  Google Scholar 

  28. M.M. Francl et al., J. Chem. Phys. 77, 3654 (1982)

    Article  CAS  Google Scholar 

  29. M.J. Frisch et al., Gaussian 03 Revision D.01 Gaussian Inc, Wallingford CT (2004)

  30. S. Miertus, E. Scrocco, J. Tomasi, J. Chem. Phys. 55, 117 (1981)

    Article  CAS  Google Scholar 

  31. C.M. Breneman, K.B. Wiberg, J. Comp. Chem. 11, 361 (1990)

    Article  CAS  Google Scholar 

  32. GaussView 3.09, Gaussian Inc., Pittsburg, PA, USA, (2003)

  33. HyperChem 8.0.3, HyperCube Inc., Gainsville, FL, USA, (2007)

  34. R.A. Kwiecień, A. Lewandowicz, P. Paneth, Chapter 7 In: J. Leszczyński (Ed.), Challenges and Advances in Computational Chemistry and Physics, W.A. Sokalski (Ed.), Vol. 4, Molecular Materials with Specific Interactions — Modeling and Design (Springer, Amsterdam, 2007), 341

    Chapter  Google Scholar 

  35. V.L. Schramm, Acc. Chem. Res. 36, 588 (2003)

    Article  CAS  Google Scholar 

  36. W.A. Carroll et al., Bioorg. Med. Chem. Lett. 17, 4044 (2007)

    Article  CAS  Google Scholar 

  37. T. Akbarzadeh, S.A. Tabatabai, M.J. Khoshnoud, B. Shafaghic, A. Shafieea, Bioorg. Med. Chem. Lett. 11, 769 (2003) and references 7, 8 therein

    Article  CAS  Google Scholar 

  38. G. Pastorin et al., J. Med. Chem. 46, 4287 (2003)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Agata Siwek.

About this article

Cite this article

Siwek, A., Wujec, M., Dobosz, M. et al. Synthesis and pharmacological properties of 3-(2-methyl-furan-3-yl)-4-substituted-Δ2-1,2,4-triazoline-5-thiones. cent.eur.j.chem. 6, 47–53 (2008). https://doi.org/10.2478/s11532-007-0058-0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11532-007-0058-0

Keywords

Navigation